MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Sensorimotor inhibition relates to gait dysfunction in people with Parkinson’s disease

    D. Martini, G. Harker, R. Morris, J. Nutt, F. Horak (Portland, OR, USA)

    Objective: To determine how sensorimotor inhibition relates to objective measures of gait OFF and ON levodopa and how having Parkinson’s disease (PD) affects this relationship.…
  • MDS Virtual Congress 2020

    Predictive factors of serious falls in Parkinson’s disease

    H. Matsumoto, M. Shiraishi, S. Tochimoto, K. Tanaka, K. Uchino, Y. Hasegawa (Kawasaki, Japan)

    Objective: We aimed to determine predictive factors for serious falls in PD by long term follow-up for four years after comprehensive evaluation both in physical…
  • MDS Virtual Congress 2020

    Motor onset of Parkinsonʼs disease: Is there a somatotopic pattern?

    M. Monje, A. Sánchez-Ferro, L. Vela-Desojo, F. Alonso-Frech, M. Di Leone, J. Pineda-Pardo, G. Foffani, J. Obeso (Móstoles, Madrid, Spain)

    Objective: To study the clinical onset and progression of motor manifestations in different body regions in early PD patients. Background: The vulnerability of the nigrostriatal…
  • MDS Virtual Congress 2020

    Relationship between tumor and very slow Parkinson`s disease progression

    H. Mori (Kurashiki, Okayama, Japan)

    Objective: We evaluate the Parkinson`s disease patients with very slow progression. One of their clinical features are the medical history of tumor. Background: Some cancer…
  • MDS Virtual Congress 2020

    Identifying biomarkers to predict disease progression in early stage Parkinson’s disease patients

    L. Neilson, J. Baird, B. Lobb, H. Vanderjagt, N. Gray, S. O'Connor, J. Quinn (Portland, OR, USA)

    Objective: To evaluate the sensitivity of instrumented measures of motor dysfunction and candidate serological markers of disease to predict disease progression in de novo Parkinson’s…
  • MDS Virtual Congress 2020

    A longitudinal study on alpha-synuclein in plasma neuronal exosomes as a biomarker for Parkinson’s disease development and progression

    M. Niu, Y. Li, G. Li, L. Zhou, N. Luo, M. Yao, W. Kang, J. Liu (Shanghai, China)

    Objective: This study explored the potential use of alpha-synuclein (α-syn) in plasma neuronal exosomes as a biomarker for early Parkinson’s disease (PD) diagnosis and disease…
  • MDS Virtual Congress 2020

    Parkinson’s disease and osteocalcin pilot study: Is there a protective role of bone in neurodegeneration?

    A.S Nordvig, R.N Alcalay, J.M Berger, K. Marder, G. Karsenty, A. Wang (New York, NY, USA)

    Objective: To characterize the relationship between the bone-derived hormone osteocalcin (OCN) and Parkinson’s disease (PD) in humans, and explore sex and treatment differences. Background: The…
  • MDS Virtual Congress 2020

    Pulmonary function in Parkinson’s disease

    A. O'Callaghan, W. Gray, S. Bourke, R. Walker (North Shields, United Kingdom)

    Objective: To establish if pulmonary function is impaired in Parkinson’s disease (PD) and define any pattern of impairment. Background: Parkinson’s disease (PD) is associated with…
  • MDS Virtual Congress 2020

    Parkinson’s disease and chronic inflammatory demyelinating polyneuropathy with celiac disease: Improvement in neuropathy but not Parkinson’s symptoms after intravenous immunoglobulin and gluten free diet

    M. Pullman, T. Brannagan, R. Saunders-Pullman (New York, NY, USA)

    Objective: To report a case of celiac disease in Parkinson's disease and CIPD, and examine the relationship. Background: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) is a…
  • MDS Virtual Congress 2020

    An agent-based model replicates the pathogenic spread of alpha-synuclein in mice

    S. Rahayel, B. Mišić, Y.Q Zheng, Z.Q Liu, A. Caputo, K. Luk, A. Dagher (Montreal, QC, Canada)

    Objective: To investigate the ability of a susceptible-infected-removed (SIR) agent-based model to predict the pathogenic spread of alpha-synuclein fibrils after injection in mice. Background: Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 1117
  • 1118
  • 1119
  • 1120
  • 1121
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley